These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 27436023

  • 41. Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation.
    Bhattacharjee R, Gupta M, Singh T, Sharma S, Khanna G, Parvaze SP, Patir R, Vaishya S, Ahlawat S, Singh A, Gupta RK.
    Neuroradiology; 2022 Sep; 64(9):1801-1818. PubMed ID: 35435463
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Multiparametric analysis from dynamic susceptibility contrast-enhanced perfusion MRI to evaluate malignant brain tumors.
    Abreu VS, Tarrio J, Silva J, Almeida F, Pinto C, Freitas D, Filipe JP.
    J Neuroimaging; 2024 Sep; 34(2):257-266. PubMed ID: 38173078
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Atypical radiological findings of primary central nervous system lymphoma.
    Lin X, Khan IRA, Seet YHC, Lee HY, Yu WY.
    Neuroradiology; 2020 Jun; 62(6):669-676. PubMed ID: 32077984
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Classification of glioblastoma versus primary central nervous system lymphoma using convolutional neural networks.
    McAvoy M, Prieto PC, Kaczmarzyk JR, Fernández IS, McNulty J, Smith T, Yu KH, Gormley WB, Arnaout O.
    Sci Rep; 2021 Jul 26; 11(1):15219. PubMed ID: 34312463
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Differentiating primary central nervous system lymphoma from glioblastoma by time-dependent diffusion using oscillating gradient.
    Kamimura K, Nakano T, Hasegawa T, Nakajo M, Yamada C, Kamimura Y, Akune K, Ejima F, Ayukawa T, Nagano H, Takumi K, Nakajo M, Higa N, Yonezawa H, Hanaya R, Kirishima M, Tanimoto A, Iwanaga T, Imai H, Feiweier T, Yoshiura T.
    Cancer Imaging; 2023 Nov 30; 23(1):114. PubMed ID: 38037172
    [Abstract] [Full Text] [Related]

  • 53. Machine Learning-based Texture Analysis of Contrast-enhanced MR Imaging to Differentiate between Glioblastoma and Primary Central Nervous System Lymphoma.
    Kunimatsu A, Kunimatsu N, Yasaka K, Akai H, Kamiya K, Watadani T, Mori H, Abe O.
    Magn Reson Med Sci; 2019 Jan 10; 18(1):44-52. PubMed ID: 29769456
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.
    Hatzoglou V, Oh JH, Buck O, Lin X, Lee M, Shukla-Dave A, Young RJ, Peck KK, Vachha B, Holodny AI, Grommes C.
    J Neurooncol; 2018 Nov 10; 140(2):351-358. PubMed ID: 30073640
    [Abstract] [Full Text] [Related]

  • 56. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A, Yamasaki F, Ohtaki M, Kajiwara Y, Takeshima Y, Watanabe Y, Takayasu T, Amatya VJ, Akiyama Y, Sugiyama K, Kurisu K.
    Eur J Radiol; 2012 Feb 10; 81(2):339-44. PubMed ID: 21129872
    [Abstract] [Full Text] [Related]

  • 57. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
    Murayama K, Nishiyama Y, Hirose Y, Abe M, Ohyu S, Ninomiya A, Fukuba T, Katada K, Toyama H.
    Magn Reson Med Sci; 2018 Jan 10; 17(1):42-49. PubMed ID: 28515410
    [Abstract] [Full Text] [Related]

  • 58. Differentiation between primary cerebral lymphoma and glioblastoma using the apparent diffusion coefficient: comparison of three different ROI methods.
    Ahn SJ, Shin HJ, Chang JH, Lee SK.
    PLoS One; 2014 Jan 10; 9(11):e112948. PubMed ID: 25393543
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Differentiation of high-grade glioma and primary central nervous system lymphoma: Multiparametric imaging of the enhancing tumor and peritumoral regions based on hybrid 18F-FDG PET/MRI.
    Zhang S, Wang J, Wang K, Li X, Zhao X, Chen Q, Zhang W, Ai L.
    Eur J Radiol; 2022 May 10; 150():110235. PubMed ID: 35290912
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.